Summit Therapeutics Inc. (NASDAQ:SMMT – Get Rating)’s stock price traded down 9.3% during trading on Thursday . The company traded as low as $2.51 and last traded at $2.55. 715,751 shares changed hands during mid-day trading, a decline of 70% from the average session volume of 2,414,631 shares. The stock had previously closed at $2.81. […]
Summit Therapeutics Inc. (NASDAQ:SMMT – Get Rating) shares gapped down prior to trading on Wednesday . The stock had previously closed at $2.46, but opened at $2.40. Summit Therapeutics shares last traded at $2.47, with a volume of 794,453 shares changing hands. Analyst Ratings Changes Separately, StockNews.com downgraded shares of Summit Therapeutics from a “hold” […]
Alpine Global Management LLC acquired a new stake in shares of Summit Therapeutics Inc. (NASDAQ:SMMT – Get Rating) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 202,928 shares of the company’s stock, valued at approximately $862,000. Alpine Global Management LLC owned approximately 0.10% […]
Shares of Summit Therapeutics Inc. (NASDAQ:SMMT – Get Rating) were down 6.1% during trading on Tuesday . The company traded as low as $1.55 and last traded at $1.55. Approximately 402,170 shares traded hands during mid-day trading, a decline of 83% from the average daily volume of 2,386,329 shares. The stock had previously closed at […]
Summit Therapeutics Inc. (NASDAQ:SMMT – Get Rating)’s stock price dropped 5.9% during mid-day trading on Wednesday . The company traded as low as $1.59 and last traded at $1.60. Approximately 375,289 shares changed hands during trading, a decline of 84% from the average daily volume of 2,420,087 shares. The stock had previously closed at $1.70. […]